Oracle's Capex Hangover Deepens as the Street Holds Conviction

The lending market is not the story here, and hasn't been all month. Borrow availability remains extraordinarily loose — nearly 4,500% of short interest — meaning roughly 45 shares are available to borrow for every one currently shorted. Cost to borrow has eased further to 0.35%, down 10% on the week. Short interest itself ticked down 4.2% on the week to 1.2% of the free float, a trivially low level. The ORTEX short score of 30.2 is stable and unremarkable. Options positioning is equally subdued: the put/call ratio of 0.92 is essentially in line with its 20-day average of 0.91, with a z-score barely above zero. The borrow market and options market are both telling the same story — short sellers are not driving this selloff, and there is no meaningful hedge demand building either.

The analyst response to the post-earnings reset has been notable for its conviction. Following the June 10 drop, firms broadly moved to raise targets rather than cut them — a deliberate signal that the Street views the selloff as a positioning event, not a fundamental deterioration. As of June 11, Bernstein lifted its target to $325 from $319, Barclays moved to $250 from $240, and DA Davidson raised to $225 from $200. TD Cowen and Cantor Fitzgerald held their Buy-equivalent ratings with targets at $300 and $284 respectively. The outlier remains Wedbush, which actually cut its target to $240 from $275 while maintaining Outperform — an implicit acknowledgment that the capex narrative has reduced near-term upside visibility even for believers. RBC Capital's Sector Perform with a $190 target, sitting just above the current price, represents the most cautious realistic floor on the Street. The consensus mean of $252.64 implies 34% upside from current levels — that gap keeps growing as the stock drifts lower without a catalyst to close it. The bull case rests on AI infrastructure demand, a 325% surge in remaining performance obligations, and raised FY27 guidance of $90 billion in revenue. The bear case points to high AI monetization expectations, intensifying competition from AWS and Azure, and the risk of large M&A ventures at a time when the market is already skeptical of capital allocation.

On valuation, the reset has made multiples more palatable but not obviously cheap. The trailing P/E has compressed to roughly 20x, down 4.2 points over the past month, and EV/EBITDA has fallen to 11.4x from over 16x a month ago. EPS momentum remains genuinely strong — ranking in the 97th percentile on the 30-day measure and 88th on the 90-day — suggesting the fundamental earnings trajectory has not broken. What has broken is the multiple investors were willing to pay for it. The mismatch between strong earnings momentum (top decile) and weak forward EPS year-on-year growth rank (31st percentile) captures the core tension: Oracle is executing well on near-term numbers, but the question of whether AI infrastructure revenue will scale fast enough to justify the growth premium investors had assigned is now openly in dispute.

The next concrete test is the absence of one: with no earnings event on the calendar, the stock trades entirely on macro tone, capex narrative updates from hyperscaler commentary, and any incremental read-through from management on AI contract conversion rates.